Related references
Note: Only part of the references are listed.Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina
Shannon E. Boye et al.
HUMAN GENE THERAPY (2016)
Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial
Nicola G. Ghazi et al.
HUMAN GENETICS (2016)
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial
Jean Bennett et al.
LANCET (2016)
Visual Acuity after Retinal Gene Therapy for Choroideremia
Thomas L. Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gene Therapy for Leber Hereditary Optic Neuropathy Initial Results
William J. Feuer et al.
OPHTHALMOLOGY (2016)
Evaluation of an Optimized Injection System for Retinal Gene Therapy in Human Patients
M. Dominik Fischer et al.
HUMAN GENE THERAPY METHODS (2016)
The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype
Matthew P. Simunovic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia
Jasleen K. Jolly et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Correlation of Optical Coherence Tomography and Autofluorescence in the Outer Retina and Choroid of Patients With Choroideremia
Kanmin Xue et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Gene therapy for age-related macular degeneration
Robert E. MacLaren
LANCET (2015)
Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
Elizabeth P. Rakoczy et al.
LANCET (2015)
Long-Term Effect of Gene Therapy on Leber's Congenital Amaurosis
J. W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Improvement and Decline in Vision with Gene Therapy in Childhood Blindness
Samuel G. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
Robert E. MacLaren et al.
LANCET (2014)
Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
Samuel G. Jacobson et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Albert M. Maguire et al.
LANCET (2009)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Share Paper
